Neo Ivy Capital Management Quidel Ortho Corp Transaction History
Neo Ivy Capital Management
- $44.7 Million
- Q4 2023
A detailed history of Neo Ivy Capital Management transactions in Quidel Ortho Corp stock. As of the latest transaction made, Neo Ivy Capital Management holds 5 shares of QDEL stock, worth $161. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5Holding current value
$161% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding QDEL
# of Institutions
294Shares Held
62.2MCall Options Held
534KPut Options Held
110K-
Carlyle Group Inc. Washington, DC12.5MShares$403 Million43.98% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.7MShares$314 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$158 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.87MShares$158 Million0.01% of portfolio
-
Rubric Capital Management LP New York, NY2.4MShares$77.7 Million3.92% of portfolio
About QuidelOrtho Corp
- Ticker QDEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 66,952,900
- Market Cap $2.17B
- Description
- QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...